sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 19/08/2009
PIL Zimovane 7.5mg & Zimovane LS 3.75mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 23/02/2009 and displayed until 19/08/2009
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 23/07/2008 and displayed until 23/02/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/07/2006 and displayed until 23/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 09/08/2005 and displayed until 24/07/2006
Reasons for adding or updating:
  • Change to drug interactions
Updated on 29/10/2003 and displayed until 09/08/2005
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Update to PIL
Updated on 08/11/2002 and displayed until 29/10/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 30/04/2002 and displayed until 08/11/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 28/11/2000 and displayed until 30/04/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 09/08/2000 and displayed until 28/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   zopiclone